<DOC>
	<DOCNO>NCT01861990</DOCNO>
	<brief_summary>The study investigate valproic acid add radiation temozolomide therapy ( standard care ) progressive recurrent pediatric brain tumor .</brief_summary>
	<brief_title>Valproic Acid Childhood Progressive Brain Tumors</brief_title>
	<detailed_description>Patients progressive recurrent pediatric brain tumor administer valproic acid , HDAC inhibitor , along standard care therapy ( radiation temozolomide ) induction therapy . Thereafter , patient able continue valproic acid temozolomide therapy long combination well tolerated tumor progressing .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Subject , parent , guardian willing able give inform consent Recurrent progressive pediatric brain tumor , MRI evidence disease Age first diagnosis brain tumor 121 year old Lansky Karnofsky performance score least 50 diagnosis Pregnancy Prior intolerance valproic acid History use temozolomide Use enzyme induce anticonvulsant medication ( see appendix B ) Known urea cycle disorder ( e.g . ornithine transcarbamylase deficiency )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Glioma</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Child</keyword>
	<keyword>Brain tumor</keyword>
	<keyword>Astrocytoma</keyword>
	<keyword>Medulloblastoma</keyword>
	<keyword>PNET</keyword>
</DOC>